Open Label, 4 Week Study of ITCA 650 in Adults With Type 2 Diabetes

NCT01798264 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: ITCA 650 (exenatide in DUROS)

Sponsor

Intarcia Therapeutics